The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of melanoma soft parts/clear cell sarcoma (MSP/CCS) patients (pts) with immune and targeted therapies.
 
Amy Little Jones
No Relationships to Disclose
 
Aron Joon
No Relationships to Disclose
 
Lauren Elaine Haydu
No Relationships to Disclose
 
Alexander J. Lazar
Employment - GE Healthcare (I)
Leadership - Archer; Beta Cat Pharmaceuticals
Stock and Other Ownership Interests - Archer; Beta Cat Pharmaceuticals
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Consulting or Advisory Role - GE Healthcare; Illumina; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Michael T. Tetzlaff
Consulting or Advisory Role - Myriad Genetics; Novartis
 
Vinod Ravi
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Michael A. Davies
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; NanoString Technologies; Novartis; Sanofi; Syndax; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)